Replies to post #6015 on VivoSim Labs Inc (VIVS)

[grantg2]

6.40... Now there's one chicken

counted today well before it hatched!

Looks like ONVO was pretty resilient today even with a couple of "assaults" on its price.

Guess there are MANY that are NOT COUNTING those little 40-day viable livers as WORTHLESS to some big pharma.

[RandolRocketman]

Actually, it's a pretty good bet that they will do business with Pfizer again.
The whole astrazenica thing is smoke in the wind, the real news will be another tie up with Organovo. The last deal Pfizer inked with Organovo was worth over 1/2 $million ($600,000) for the original 40 day liver assays as an R&D project.
Having that business relationship already in place makes further deals that much easier, as anyone doing business with a large corp could tell you. Once you get your foot in the door, and Pfizer gets comfortable when a deal goes through like it did. Success breeds success. And others on this board have noted they know insiders at Pfizer and there is a lot of buzz about the ONVO printed tissues.
Let's also not forget L'oreal using Organovo printed skin tissue for their next gen skin care products.
And the Michael J Fox organisation working with Parkinson's could be a huge customer for testing samples of organ tissues...
Just sayin there is sooo much upside here.